NDC properties for "TOLBUTamide 500 MG Oral Tablet" (RxCUI 198294)
About this data
The tables show NDC propoerties for TOLBUTamide 500 MG Oral Tablet with the RxCUI 198294
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for TOLBUTamide 500 MG Oral Tablet (RxCUI 198294)
| MMSL_CODE | BD2945 |
|---|---|
| MMSL_CODE | CD2945 |
| RxCUI | 198294 |
| SNOMEDCT | 325267004 |
| VUID | 4002661 |
| Prescribable Synonym | TOLBUTamide 500 MG Oral Tablet |
| RXNAV_STR | TOLBUTamide 500 MG Oral Tablet |
| RxNorm Name | tolbutamide 500 MG Oral Tablet |
| Tallman Synonym | TOLBUTamide 500 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 198294) |
NDC Properties
NDC Item 00378021501
| NDC 9 | 0378-0215 |
|---|---|
| NDC 10 | 0378-0215-01 |
| NDC Item | 00378021501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0215-01) |
| ANDA | ANDA086445 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 407194 |
| Imprint code | M;13 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-09-30 |
| Marketing effective time low | 1989-11-01 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0378-0215 |
NDC Item 00378021505
| NDC 9 | 0378-0215 |
|---|---|
| NDC 10 | 0378-0215-05 |
| NDC Item | 00378021505 |
| Packaging | 500 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA086445 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 407194 |
| Imprint code | M;13 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-09-30 |
| Marketing effective time low | 1989-11-01 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0378-0215 |
NDC Item 00378021501
| NDC 9 | 0378-0215 |
|---|---|
| NDC 10 | 0378-0215-01 |
| NDC Item | 00378021501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0215-01) |
| ANDA | ANDA086445 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 407194 |
| Imprint code | M;13 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-09-30 |
| Marketing effective time low | 1989-11-01 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0378-0215 |
NDC Item 00378021505
| NDC 9 | 0378-0215 |
|---|---|
| NDC 10 | 0378-0215-05 |
| NDC Item | 00378021505 |
| Packaging | 500 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA086445 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 407194 |
| Imprint code | M;13 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-09-30 |
| Marketing effective time low | 1989-11-01 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0378-0215 |